Meet the media team
Find a media contact in your region
Total 25 Results for:
Showing 12 out of 25 results
10 July 2024
Herbert Smith Freehills advises EQT and Icon Group on its acquisition of the Pharmaxo Group
Leading international law firm Herbert Smith Freehills has advised EQT Partners (EQT), a global investment firm and one of the world's largest private …
13 June 2024
Herbert Smith Freehills advises sole sponsor and overall coordinators on QuantumPharm's Hong Kong IPO
Leading international law firm Herbert Smith Freehills has advised CITIC Securities (Hong Kong) Limited as the Sole Sponsor and CLSA Limited, China …
15 November 2023
Herbert Smith Freehills appoints new Pharma Co-Head
Herbert Smith Freehills has appointed Chris Parker KC as Co-Head of the firm's Pharmaceuticals group.Chris is a partner specialising in international …
1 November 2023
Herbert Smith Freehills advises Zydus Lifesciences Limited on acquisition of the UK based LiqMeds Group
Leading international law firm Herbert Smith Freehills has advised Zydus Pharmaceuticals UK Limited, a 100% subsidiary of Indian multinational …
12 June 2023
Herbert Smith Freehills advises sole sponsor and overall coordinators on Cutia Therapeutics' Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人和整体协调人律师为科笛集团香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on Cutia Therapeutics (02487.HK)'s …
15 December 2022
Herbert Smith Freehills advises joint sponsors on 3D Medicines' Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为思路迪香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised CICC and CSCI as joint sponsors of 3D Medicines Inc. (01244.HK)’s mainboard listing on …
18 November 2022
Herbert Smith Freehills and Hiswara Bunjamin & Tandjung advise Silk Road Fund on investment in Indonesian pharmaceutical SOEs 史密夫斐尔及Hiswara Bunjamin & Tandjung为丝路基金投资印尼国有制药企业提供法律咨询
Leading international law firm Herbert Smith Freehills and its associate firm Hiswara Bunjamin & Tandjung have advised China's Silk Road Fund on a …
1 September 2022
Herbert Smith Freehills advises sponsors on Biocytogen Pharmaceuticals' Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为百奥赛图香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and …
19 August 2022
Herbert Smith Freehills advises Sanofi on €300 million equity investment in Innovent 史密夫斐尔律师事务所就赛诺菲对信达生物3亿欧元股权投资提供法律服务
Leading international law firm Herbert Smith Freehills has advised innovative global healthcare company Sanofi on its €300 million strategic equity …
23 February 2022
Herbert Smith Freehills advises sponsors and underwriters on Lepu Biopharma's Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为乐普生物香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised CICC and Morgan Stanley as joint sponsors and the underwriters of biopharmaceutical …
13 July 2021
Herbert Smith Freehills advises sponsors on Brii Biosciences’ HK$2.483 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为腾盛博药24.83亿港元IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised Morgan Stanley and UBS as joint sponsors of biopharmaceutical company Brii Biosciences …
27 November 2020
Herbert Smith Freehills advises on Gland Pharma’s US$872 million India IPO / 史密夫斐尔律师事务所为Gland Pharma 8.72亿美元印度IPO提供法律服务
Leading global law firm Herbert Smith Freehills has advised the book running lead managers on the global offering and listing of Gland Pharma Limited on …
Showing 12 out of 25 results
View moreSearchlight AI
Our new tracking tool keeps you current with developments in artificial intelligence in all major markets